Clinical trial · Interventional
Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer
To Develop and Implement a Method for Medical Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer
NCT04588935CI-TRIAL-00063714completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Women With Breast Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bisoprolol; Perindopril; | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Group 1
- description
- women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy, untreated
- type
- ACTIVE_COMPARATOR
- label
- Group 2
- description
- women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy, receiving treatment with a combination of bisoprolol and perindopril
- interventionNames
- Drug: Bisoprolol; Perindopril;
Primary outcomes (1)
- measure
- development of cardiovascular diseases and complications
- timeFrame
- 4 years
- description
- hypertension, cardiomyopathy, arrhythmia's, myocardial infarction, heart failure
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy. Exclusion Criteria: * presence of other oncological diseases
References
Publications (0)
Data not yet available
No reference posted for this study.